In a preliminary diagnosis, it was concluded that the patient’s hypercalcemia was caused by an inactivating CaSR mutation based on the clinical lab results and sequence analysis of hypercalcemia-related genes. This evidence concerns the gene CASR and hypercalcemia disease.